This role is responsible for developing and leading the global growth strategy for the pancreaticobiliary portfolio including Beacon and Dragonfly technologies.
Base: $133,600.00 - $200,400.00 USD; Bonus/Equity: Eligible for Medtronic Incentive Plan (MIP); Benefits: Health, Dental, Vision, 401(k), PTO, Tuition Assistance
Must-have
Nice-to-have
Must have unrestricted US work authorization at time of hire